Al-Dury S, Wahlström A, Wahlin S, et al. Pilot Study with IBAT Inhibitor A4250 for the Treatment of Cholestatic Pruritus in Primary Biliary Cholangitis. AASLD 2017, abstract 69.
Epcoritamab en tislelizumab in de sluis geplaatst
nov 2023 | Lymfoom, Maag-darm-leveroncologie